Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orthogonal Diagnostics
San Diego, California, United Statesobi.bio ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Commercial
01
Overview
Orthogonal Diagnostics has developed and commercialized the obi at-home saliva test for measuring cortisol levels as an indicator of stress. The product provides visual results within 20 minutes and does not require mail-in kits or lab processing. The company leverages proprietary lateral flow technology and focuses on consumer health monitoring with real-time access to physiological data.
- Therapeutic areas
- PsychiatryEndocrinology
- Modalities
- DeviceDiagnostic test systemLateral flow technology (for saliva-based diagnostics)
- Industry
- Metabolite Diagnostics
02
Partnerships
Abbott (contract projects)Quest Diagnostics (contract projects)
Beyond the preview
Go deeper on Orthogonal Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Orthogonal Diagnostics.